FDA pilots new inspection programme
This article was originally published in Clinica
FDA officials have introduced a pilot programme to make plant inspections more compatible with the agency's 1997 quality systems regulation (QSR) which updates the agency's good manufacturing practices requirements by embracing the quality systems approach to manufacturing.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.